Home Online Features Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
Hand-out
Press Releases
Rege Nephro CO., Ltd.  
April 15, 2025

Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials

KYOTO, Japan, April 15, 2025 /PRNewswire/ -- Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tamibarotene-related clinical and non-clinical

Salamanca Press

Local & Social
Latest news for you
Community works together to clean up Salamanca
Featured, Local News, News, ...
Community works together to clean up Salamanca
DEB EVERTS Press Reporter 
April 29, 2025
SALAMANCA — In observance of Earth Day, which officially took place earlier in the week, Salamanca area residents of all ages set out Saturday morning...
Read More...
Cattaraugus County Source
ePaper
google_play
app_store
This Week's Ads
Current e-Edition
ePaper
google_play
app_store
Already a subscriber? Click the image to view the latest e-edition.
Don't have a subscription? Click here to see our subscription options.
Mobile App

Download Now

The Salamanca Press mobile app brings you the latest local breaking news, updates, and more. Read the Salamanca Press on your mobile device just as it appears in print.

ePaper
google_play
app_store
Trending Recipes

Help Our Community

Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve our community. The survey is at: www.pulsepoll.com $1,000 is being awarded. Everyone completing the survey will be able to enter a contest to Win as our way of saying, "Thank You" for your time. Thank You!